Search for: "Kluwer Patent Blog"
Results 961 - 980
of 1,000
Sort by Relevance
|
Sort by Date
12 Apr 2011, 10:07 pm
Infringement proceedings by the European Commission against Italy (Kluwer Patent Blog) India approves free access to important portions of the Traditional Knowledge Digital Library (TK Community) (Spicy IP) USPTO proposes changes to PTA and PTE provisions (Patent Docs) US: FDA issues warning letter for failure to submit animal study reports in an IDE (FDA Law Blog) US: AMP v USPTO – oral argument at the Federal Circuit (Patent Docs) US: A… [read post]
4 Apr 2011, 5:10 am
(ITC Law Blog) High rate of patent throughput continues in 2011(Patently-O) Should the PTO’S reexamination analysis impact ITC cases? [read post]
29 Mar 2011, 9:19 pm
Merck (Kluwer Patent Blog) Keppra (Levetiracetam) – US: Orange Book patent listing precipitates DJ action to trigger generic Keppra XR 180-day exclusivity forfeiture: Par Pharmaceutical v UCB et al (FDA Law Blog) (Patent Docs) Naropin (Ropivacaine) – US: Judge O’Malley in dissent: Patent assignments should be a matter of state law: Abraxis BioScience v. [read post]
21 Mar 2011, 9:01 am
[The Netherlands] : Kluwer Law International, c2010- Social MediaKFP81 .P4 No.6610Facebook, twitter & blogging...oh myspace! [read post]
18 Mar 2011, 10:01 pm
(Kluwer Patent Blog) (IAM) (ipeg) (BLOG@IP::JUR) (inovia’s Foreign Filing Blog) (Kluwer Patent Blog) (IP Spotlight) (PatLit) (IPKat) (PatLit) (EPLAW) Senate passes S. 23 (95-5) / ??????? [read post]
16 Mar 2011, 3:50 am
Actavis (Kluwer Patent Blog) Valsartan – Norway: Valsartan case goes on appeal: Novartis v Actavis (The SPC Blog) Xeloda (Capecitabine) – US: Hoffmann-La Roche files patent infringement complaint against Accord following Para IV challenge (Patent Docs) [read post]
14 Mar 2011, 4:59 am
Highlights this week included: European Court of Justice trashes planned unified patent litigation system : Avis 1/09 (Kluwer Patent Blog) (IAM) (ipeg) (BLOG@IP::JUR) (inovia’s Foreign Filing Blog) (Kluwer Patent Blog) (IP Spotlight) (PatLit) (IPKat) (PatLit) (EPLAW) Senate passes S. 23 (95-5) (Patent Docs) (IPBiz) (IP Whiteboard) (Patent Docs) (Inventive Step) (IP Spotlight) (Blawg IT)… [read post]
14 Mar 2011, 1:46 am
Especially, "the patent world does not want the same court system that was established for community trademarks", as added on the Kluwer blog. [read post]
8 Mar 2011, 9:55 pm
Meanwhile, for those who love password-protected blogs, Kluwer has just set up the Kluwer Copyright Blog, here. [read post]
1 Mar 2011, 8:38 pm
: Albany Molecular Research v Alphapharm (Patentology) (IP Whiteboard) (IP Whiteboard) Glivec (Imatinib) – India: Novartis asked to end challenge to Indian patent law (GenericsWeb) Humira (Adalimumab) – US: $1.67B verdict overturned by CAFC, patent invalidated over written description: Centocor v Abbott (Peter Zura’s 271 Patent Blog) (Patently-O) (Patently-O) (Patent Law Practice Center) (Patent Docs) (IPBiz)… [read post]
27 Feb 2011, 9:49 pm
(Kluwer Patent Blog) IP renaissance and IP baroque: A coda on IP milestones (IP Kat) Jurisdiction to deal with foreign patents: Solvay goes all the way: Solvay S.A v Honeywell Fluorine Products Europe B.V., Honeywell Belgium N.V. and Honeywell Europe N.V. [read post]
23 Feb 2011, 3:35 am
(Patentology) China: Patentability of dosage regime invention in the form of Swiss-type claim under Chinese patent law (jiplp) US: Legislation to ban authorized generics during 180-day exclusivity period makes a comeback in Congress (FDA Law Blog) US: Market exclusivity, data exclusivity and S. 3921 (Holman’s Biotech IP Blog) US: President’s budget proposal increases funding for basic research but seeks to ‘trim’ data exclusivity period and… [read post]
20 Feb 2011, 9:44 pm
(Kluwer Patent Blog) Looking for the final questions for the ECJ in the Onel case? [read post]
11 Feb 2011, 3:59 am
(IP Dragon) Europe Competition trumps IP in footie decoder pub brawl: Football Association Premier League Ltd & Others v QC Leisure & Others, Karen Murphy v Media Protection Services Ltd (IPKat) (1709 Blog) (1709 Blog) (IPKat) (Azrights) EPO puts an end to the practice of resurrecting invalid claims in a divisional application: T 0051/08 Res iudicata in a divisional application/CANON (Kluwer Patent Blog) Greece Police arrest five in operation to… [read post]
8 Feb 2011, 10:51 pm
(IP Watch) (Michael Geist) UK: ‘Patent box’ tax incentives and SPCs in the UK (The SPC Blog) US: BIO commends Senate Judiciary Committee passage of Patent Reform Act of 2011 (PatentlyBIOtech) US: Sen. [read post]
7 Feb 2011, 2:58 am
(Kluwer Patent Blog) Sweden Stockholm District Court costs decision – Centraction v. [read post]
2 Feb 2011, 3:52 am
Highlights this week included: India, South Africa gain from J&J generic deal, Patent Pool loses out (Spicy IP) (KEI) Advair (Fluticasone propionate, Salmeterol) – Netherlands: GSK reverse on Dutch Advair patent and SPC (The SPC Blog) (The SPC Blog) (Kluwer Patent Blog) Brazilian Attorney General of the Union restricts ANVISA’s role in pharmaceutical patent review (PatentlyBIOtech) Please join the discussion by… [read post]
31 Jan 2011, 3:19 am
OHIM (Class 46) 2011 IP Developments Conference updates: 1 to 4 (IPKat) (IPKat) (IPKat) (IPKat) Germany Pirate Party general assembly announced (1709 Blog) Effective measures for securing evidence have been instituted (Kluwer Patent Blog) Is Heidi the cross-eyed opossum, the new Paul? [read post]
25 Jan 2011, 10:58 pm
General GSK critiques Anti-Counterfeiting Trade Agreement (IP Watch) WHO Members show dismay at delay on Counterfeit Medicines Group (IP Watch) WHO R&D financing committee approved with controversial industry expert (IP Watch) (KEI) (KEI) (KEI) BioCentury this week explores orphan drugs with HP&M attorney and NORD Board Chair (FDA Law Blog) EU: Paediatric extensions and transitional provisions: a question of timing (The SPC Blog) India: Patent Office continue… [read post]
23 Jan 2011, 8:25 pm
McNeil AB, (Kluwer Patent Blog) Switzerland No peace for Buddha Bar in Switzerland (Class 46) United Kingdom PCC Page 12: Robot Octopus takes a break? [read post]
